Journal of Extracellular Vesicles,
Journal Year:
2023,
Volume and Issue:
12(2)
Published: Feb. 1, 2023
Extracellular
vesicles
(EVs)
are
cell-released,
heterogenous
nanoparticles
that
play
important
roles
in
(patho)physiological
processes
through
intercellular
communication.
EVs
often
depicted
as
having
a
single
lipid
bilayer,
but
many
studies
have
demonstrated
the
existence
of
multilayered
EVs.
There
has
been
minimal
inquiry
into
differences
between
unilamellar
and
multilamellar
terms
biogenesis
mechanisms
functional
effects.
This
commentary
speculates
on
potential
causes
serves
call
to
action
for
research
community
unravel
complex
layers
Journal of Extracellular Vesicles,
Journal Year:
2024,
Volume and Issue:
13(2)
Published: Feb. 1, 2024
Extracellular
vesicles
(EVs),
through
their
complex
cargo,
can
reflect
the
state
of
cell
origin
and
change
functions
phenotypes
other
cells.
These
features
indicate
strong
biomarker
therapeutic
potential
have
generated
broad
interest,
as
evidenced
by
steady
year-on-year
increase
in
numbers
scientific
publications
about
EVs.
Important
advances
been
made
EV
metrology
understanding
applying
biology.
However,
hurdles
remain
to
realising
EVs
domains
ranging
from
basic
biology
clinical
applications
due
challenges
nomenclature,
separation
non-vesicular
extracellular
particles,
characterisation
functional
studies.
To
address
opportunities
this
rapidly
evolving
field,
International
Society
for
Vesicles
(ISEV)
updates
its
'Minimal
Information
Studies
Vesicles',
which
was
first
published
2014
then
2018
MISEV2014
MISEV2018,
respectively.
The
goal
current
document,
MISEV2023,
is
provide
researchers
with
an
updated
snapshot
available
approaches
advantages
limitations
production,
multiple
sources,
including
culture,
body
fluids
solid
tissues.
In
addition
presenting
latest
art
principles
research,
document
also
covers
advanced
techniques
that
are
currently
expanding
boundaries
field.
MISEV2023
includes
new
sections
on
release
uptake
a
brief
discussion
vivo
study
Compiling
feedback
ISEV
expert
task
forces
more
than
1000
researchers,
conveys
research
facilitate
robust
discoveries
move
field
forward
even
rapidly.
Journal of Extracellular Vesicles,
Journal Year:
2022,
Volume and Issue:
11(6)
Published: June 1, 2022
Abstract
Extracellular
vesicles
(EVs)
play
a
key
role
in
many
physiological
and
pathophysiological
processes
hold
great
potential
for
therapeutic
diagnostic
use.
Despite
significant
advances
within
the
last
decade,
issue
of
EV
storage
stability
remains
unresolved
under
investigated.
Here,
we
aimed
to
identify
conditions
stabilizing
EVs
comprehensively
compared
impact
various
buffer
formulations
at
different
temperatures
on
derived
from
cellular
sources
up
2
years.
features
including
concentration,
diameter,
surface
protein
profile
nucleic
acid
contents
were
assessed
by
complementary
methods,
engineered
containing
fluorophores
or
functionalized
proteins
utilized
compare
uptake
ligand
binding.
We
show
that
storing
PBS
over
time
leads
drastically
reduced
recovery
particularly
pure
samples
all
tested,
starting
already
days.
further
report
using
as
diluent
was
found
result
severely
rates
minutes.
Several
tested
new
largely
prevented
observed
effects,
lead
candidate
being
supplemented
with
human
albumin
trehalose
(PBS‐HAT).
PBS‐HAT
facilitates
clearly
improved
short‐term
long‐term
preservation
stored
‐80°C,
throughout
several
freeze‐thaw
cycles,
when
downstream
applications.
Journal of Extracellular Vesicles,
Journal Year:
2022,
Volume and Issue:
11(2)
Published: Jan. 31, 2022
Abstract
Mounting
evidence
suggests
that
storage
has
an
impact
on
extracellular
vesicles
(EVs)
properties.
While
−80°C
is
a
widespread
approach,
some
authors
proposed
improved
strategies
with
conflicting
results.
Here,
we
designed
systematic
study
to
assess
the
of
and
freeze‐thaw
cycles
EVs.
We
tested
differences
among
eight
investigated
possible
fusion
phenomena
occurring
during
storage.
EVs
were
collected
from
human
plasma
murine
microglia
culture
by
size
exclusion
chromatography
ultracentrifugation,
respectively.
The
analysis
included:
concentration,
zeta
potential
(tunable
resistive
pulse
sensing),
contaminant
protein
assessment;
flow
cytometry
for
two
single
fluorescent‐tagged
populations
(GFP
mCherry),
mixed
before
preservation.
found
reduces
concentration
sample
purity
in
time‐dependent
manner.
Furthermore,
it
increases
particle
variability
modifies
potential,
shift
size‐charge
plots.
None
conditions
prevented
observed
effects.
Freeze‐thaw
lead
reduction
after
first
cycle
cycle‐dependent
increase
size.
With
cytometry,
storage,
significant
population
double‐positive
+
‐mCherry
).
This
observation
may
suggest
occurrence
Our
findings
show
samples
terms
loss,
leading
artefactual
particles.
Depending
downstream
analyses
experimental
settings,
should
probably
be
processed
fresh,
non‐archival,
majority
cases.
Theranostics,
Journal Year:
2022,
Volume and Issue:
12(15), P. 6548 - 6575
Published: Jan. 1, 2022
Extracellular
vesicles,
especially
small
extracellular
vesicles
(sEVs)
are
now
accepted
as
important
messengers
in
cell-to-cell
communication
and
a
promising
drug
delivery
platform.They
involved
nearly
all
physiological
pathological
processes
disease
diagnosis
therapy.However,
their
heterogeneity
of
physicochemical
properties
functions
is
not
fully
understood,
which
hinders
further
clinical
applications.To
obtain
highly
bioactive
sEVs
with
both
high
yield
purity,
will
certainly
facilitate
future
study
application.This
review
informs
up-to-date
research
on
frequently-used
cutting-edge
technologies
isolation
makes
deep
comparison
analysis
different
methods,
including
advantages,
limitations
applications.Pending
questions
about
the
inherent
property
these
well
strategies
discussed.Additionally,
an
overview
applications
treatment,
some
on-going
trials,
also
reviewed.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(24)
Published: Jan. 2, 2023
Abstract
Extracellular
vesicles
(EVs)
are
heterogeneous,
phospholipid
bilayer‐enclosed
biological
particles
that
regulate
cell
communication
by
molecular
cargo
delivery
and
surface
signaling.
EVs
secreted
almost
all
living
cells,
including
plant
cells.
Plant‐derived
vesicle‐like
nanoparticles
(PDVLNs)
is
a
generic
term
referring
to
nanostructure
isolated
from
plants.
Their
low
immunogenicity
wide
availability
make
PDVLNs
safer
more
economical
be
developed
as
therapeutic
agents
drug
carriers.
Accumulating
evidence
indicates
the
key
roles
of
in
regulating
interkingdom
crosstalk
between
humans
capable
entering
human‐body
systemand
delivering
effector
molecules
cells
modulate
cell‐signaling
pathways.
released
or
obtained
plants
thus
have
great
influenceon
human
health
diseases.
In
this
review,
biogenesis,
detailed
preparation
methods,
various
physical
biochemical
characteristics,
biosafety,
preservation
introduced,
along
with
how
these
characteristics
pertain
their
biosafety
preservability.
The
potential
applications
on
different
mammalian
diseases
PDVLN
research
standardization
then
systematically
discussed.
Journal of Nanobiotechnology,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: April 22, 2022
Abstract
Background
Steatotic
livers
tolerate
ischemia–reperfusion
injury
(IRI)
poorly,
increasing
the
risk
of
organ
dysfunction.
Ferroptosis
is
considered
initiating
factor
IRI.
Heme
oxygenase
oxygen-1
(HO-1)-modified
bone
marrow
mesenchymal
stem
cells
(BMMSCs)
(HO-1/BMMSCs)
can
reduce
hepatic
IRI;
however,
role
ferroptosis
in
IRI
steatotic
grafts
and
effect
HO-1/BMMSCs-derived
exosomes
(HM-exos)
on
remain
unknown.
Methods
A
model
rat
liver
transplantation
(LT)
with
a
severe
donor
hypoxia
reoxygenation
(H/R)
hepatocytes
were
established.
Exosomes
obtained
by
differential
centrifugation,
differentially
expressed
genes
(DEGs)
after
HM-exo
treatment
detected
using
RNA
sequencing.
The
expression
markers
was
analyzed.
microRNA
(miRNA)
sequencing
used
to
analyze
miRNA
profiles
HM-exos.
Results
We
verified
candidate
H/R
treated
hepatocytes,
observed
knockout
ferroptosis.
In
vitro,
reduced
grafts,
enrichment
analysis
DEGs
suggested
that
HM-exos
involved
regulation
pathway.
inhibition
hepatocyte
injury.
contained
more
abundant
miR-124-3p,
which
H/R-treated
inhibiting
prostate
six
transmembrane
epithelial
antigen
3
(STEAP3),
while
overexpression
Steap3
reversed
mir-124-3p.
addition,
from
cell
knocked
out
for
miR-124-3p
showed
weakened
inhibitory
Similarly,
increased
content
decreasing
level
STEAP3
reducing
degree
Conclusion
during
LT
liver.
downregulates
inhibit
ferroptosis,
thereby
attenuating
graft
IRI,
might
be
promising
strategy
treat
grafts.
Graphical
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(14), P. 7986 - 7986
Published: July 20, 2022
Extracellular
vesicles
(EVs)
are
minute
with
lipid
bilayer
membranes.
EVs
secreted
by
cells
for
intercellular
communication.
Recently,
have
received
much
attention,
as
they
rich
in
biological
components
such
nucleic
acids,
lipids,
and
proteins
that
play
essential
roles
tissue
regeneration
disease
modification.
In
addition,
can
be
developed
vaccines
against
cancer
infectious
diseases,
the
vesicle
membrane
has
an
abundance
of
antigenic
determinants
virulent
factors.
therapeutic
applications
typically
collected
from
conditioned
media
cultured
cells.
However,
number
is
limited.
Thus,
it
critical
to
devise
new
strategies
large-scale
production
EVs.
Here,
we
discussed
utilized
researchers
scalable
Techniques
bioreactors,
mechanical
stimulation,
electrical
thermal
magnetic
field
topographic
clue,
hypoxia,
serum
deprivation,
pH
modification,
exposure
small
molecules,
nanoparticles,
increasing
intracellular
calcium
concentration,
genetic
modification
been
used
improve
secretion
nitrogen
cavitation,
porous
extrusion,
sonication
prepare
EV-mimetic
nanovesicles
share
many
characteristics
naturally
Apart
inducing
EV
production,
these
upscaling
interventions
also
reported
modify
EVs'
cargo
thus
their
functionality
potential.
summary,
imperative
identify
a
reliable
technique
produce
large
quantities
consistently.
Ideally,
produced
should
possess
improved
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
12(28)
Published: July 8, 2023
Extracellular
vesicles
(EVs)
occur
in
a
variety
of
bodily
fluids
and
have
gained
recent
attraction
as
natural
materials
due
to
their
bioactive
surfaces,
internal
cargo,
role
intercellular
communication.
EVs
contain
various
biomolecules,
including
surface
cytoplasmic
proteins;
nucleic
acids
that
are
often
representative
the
originating
cells.
can
transfer
content
other
cells,
process
is
thought
be
important
for
several
biological
processes,
immune
responses,
oncogenesis,
angiogenesis.
An
increased
understanding
underlying
mechanisms
EV
biogenesis,
composition,
function
has
led
an
exponential
increase
preclinical
clinical
assessment
biomedical
applications,
such
diagnostics
drug
delivery.
Bacterium-derived
vaccines
been
use
decades
few
EV-based
diagnostic
assays
regulated
under
Clinical
Laboratory
Improvement
Amendments
approved
single
laboratories.
Though,
products
yet
receive
widespread
approval
from
national
regulatory
agencies
United
States
Food
Drug
Administration
(USFDA)
European
Medicine
Agency
(EMA),
many
late-stage
trials.
This
perspective
sheds
light
on
unique
characteristics
EVs,
highlighting
current
trends,
emerging
challenges
future
perspectives
use.